Filing Details
- Accession Number:
- 0001689325-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-15 20:45:44
- Reporting Period:
- 2023-08-14
- Accepted Time:
- 2023-08-15 20:45:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689325 | R Antonio Pera | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-14 | 3,000 | $60.37 | 33,627 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive.
Billionaire Hedge Funds
